Sionna Therapeutics

SIONNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.304 B

$51.04 +2.88%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$75.3M

Loss-making

Shares outstanding

45,212,399

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#97Vera TherapeuticsVERA$2.36B
#98Bausch Health CompaniesBHC$2.34B
#99Sionna TherapeuticsSION$2.30B
#100Nuvation BioNUVB$2.30B
#101UroGen PharmaURGN$2.30B

Where these numbers come from

Share counts and financials for Sionna Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.